Good Manufacturing Practice Validation and Radiation Dosimetry for the Clinical Application of a Novel α7-nAChR Radioligand: [11C]KIn83
Molecules · 2025
DOI: 10.3390/molecules30061356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Zhisheng Jia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, 171 77 Stockholm, Sweden. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Carbon Radioisotopes, Radiometry, Radiopharmaceuticals. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Foundation for Strategic Research, Hungarian National Research, Development and Innovation Office under the Research Grant Hungary scheme.
Abstract (Originalsprache)
Nicotinic acetylcholine receptor (α7-nAChR) plays a crucial role in cognitive functions like memory and attention. Positron emission tomography (PET) imaging of α7-nAChR is gaining attraction for understanding and monitoring central nervous system disorders, such as Alzheimer’s disease, Parkinson’s disease, and schizophrenia. We developed [11C]KIn83, a novel α7-nAChR radioligand, and evaluated its biological properties. This study focused on two objectives: (1) to validate its Good Manufacturing Practice (GMP)-compliant production, and (2) to assess the dosimetry of [11C]KIn83 using non-human primate (NHP) whole-body PET data. Radiolabeling and drug product delivery of [11C]KIn83 were conducted using an automated synthesis module within a controlled GMP environment. The quality control tests performed adhered to the European Pharmacopoeia guidelines. The production of [11C]KIn83 was validated according to GMP standards, encompassing automated synthesis and quality control measures. For the dosimetry assessment, two female cynomolgus monkeys underwent whole-body PET scans. The radioactivity values injected for [11C]KIn83 were 150 MBq and 155 MBq, respectively, with an estimated radiation dose of 0.0047 mSv/MBq. Our findings pave the way for future clinical studies that investigate the potential of [11C]KIn83 to measure α7-nAChR, aiding our understanding and possibly supporting diagnoses of different cognitive disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm County Council, 171 77 Stockholm, Sweden.
- Division of X-ray Photon Science, Uppsala University, 751 20 Uppsala, Sweden.
- Department of Chemistry, Uppsala University, 751 20 Uppsala, Sweden.
- Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 141 52 Stockholm, Sweden.
- Theme Inflammation and Aging, Karolinska University Hospital, 141 52 Stockholm, Sweden.
- HUN-REN TKI, Department of Biophysics and Radiation Biology, Semmelweis University, 1094 Budapest, Hungary.
ORCID-Profile: Zhisheng Jia, Martin Bolin, Heba Asem, Hans Ågren, Agneta Nordberg, Sangram Nag
Förderung
- Swedish Foundation for Strategic Research
- Hungarian National Research, Development and Innovation Office under the Research Grant Hungary scheme
Zitieren
APA
Jia, Z., Bolin, M., Morén, A. F., Datta, P., Asem, H., Ågren, H., Långström, B., Nordberg, A., Halldin, C., & Nag, S. (2025). Good Manufacturing Practice Validation and Radiation Dosimetry for the Clinical Application of a Novel α7-nAChR Radioligand: [11C]KIn83. Molecules. https://doi.org/10.3390/molecules30061356
Vancouver
Jia Z, Bolin M, Morén AF, Datta P, Asem H, Ågren H, et al. Good Manufacturing Practice Validation and Radiation Dosimetry for the Clinical Application of a Novel α7-nAChR Radioligand: [11C]KIn83. Molecules. 2025. doi:10.3390/molecules30061356
BibTeX
@article{Jia2025,
author = {Jia, Zhisheng and Bolin, Martin and Morén, Anton Forsberg and Datta, Prodip and Asem, Heba and Ågren, Hans and Långström, Bengt and Nordberg, Agneta and Halldin, Christer and Nag, Sangram},
title = {Good Manufacturing Practice Validation and Radiation Dosimetry for the Clinical Application of a Novel α7-nAChR Radioligand: [11C]KIn83},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30061356}
}
EUVIMED